Page 11 - பல்கலைக்கழகம் ஆஃப் வாஷிங்டன் நிறுவனம் க்கு ஆரோக்கியம் அளவீடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gupta, a professor at the University of Washington s Institute for Health Metrics and Evaluation, told  The News with Shepard Smith that AstraZeneca, when combined with a Pfizer or Moderna booster, is showing tremendous levels of protection against delta, in terms of the antibody levels that are generated in patients. I do think that those one-shot J&Jer s should be given the opportunity, while we complete our clinical trial . I m already telling my patients to do it, if they can get access to it.   Gupta s comments come on the heels of a new study from a lab at New York University Tuesday that raises serious questions about the effectiveness of J&J s single-dose vaccine against the highly contagious delta variant. The NYU study is not yet peer reviewed, but found that the antibody levels in those who received the J&J shot may be low enough to be less protective.

United statesShepard smithMeg tirrellJohnson covidVin guptaNed landauCenters for diseaseYork universityUniversity of washington institute for health metricsHealth metricsNew york university tuesdayDisease controlஒன்றுபட்டது மாநிலங்களில்ஷெப்பர்ட் ஸ்மித்மெக் திர்ரெல்ல்வின் குப்தா